A novel calcimimetic evocalcet for the management of secondary hyperparathyroidism with little effect on the gastrointestinal tract and cyp isozymes in vivo and in vitro
In the treatment of secondary hyperparathyroidism of end-stage chronic kidney disease, vitamin D receptor activation and allosteric modulators of the calcium-sensing receptor - inhibit glandular hyperplasia; reduce parathyroid hormone levels, impact on bone turnover and mineral density. Cinacalcet,...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrinology Research Centre
2020-06-01
|
| coleção: | Остеопороз и остеопатии |
| Assuntos: | |
| Acesso em linha: | https://osteo-endojournals.ru/osteo/article/viewFile/12309/pdf |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|